Related Experiment Video
Updated: Mar 14, 2026
10:11
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
37.1K
Toward an Effective Ebola Virus Vaccine
Rohan Keshwara1, Reed F Johnson2, Matthias J Schnell1
1Department of Microbiology and Immunology, Sidney Kimmel Medical College,Thomas Jefferson University, Philadelphia, Pennsylvania 19107;
Annual Review of Medicine
|October 1, 2016
Summary
Developing effective Ebola virus (EBOV) vaccines is crucial for controlling outbreaks. This overview highlights recent advancements in creating safe and protective EBOV vaccines to combat filovirus threats.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Viral outbreaks necessitate vaccines for acquired resistance and protection.
- Established immunity limits disease spread and reduces mortality during epidemics.
- Developing safe and effective Ebola virus (EBOV) vaccines remains a significant challenge.
Purpose of the Study:
- To provide a comprehensive overview of current progress in Ebola virus vaccine development.
- To highlight innovative strategies being employed against EBOV and related filoviruses.
- To inform researchers and public health officials about the state of EBOV vaccine research.
Main Methods:
- Review of recent scientific literature on EBOV vaccine candidates.
- Analysis of diverse vaccine platforms and strategies.
- Assessment of preclinical and clinical trial data.
Main Results:
- Various inventive strategies are being explored for EBOV vaccine development.
- Progress has been made in understanding immune responses to filoviruses.
- Challenges in achieving both safety and efficacy persist.
Conclusions:
- Continued research and development are essential for a successful EBOV vaccine.
- Innovative approaches offer promise in counteracting filovirus threats.
- Vaccine development is key to long-term control of viral outbreaks like Ebola.
